학술논문

WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Insulin and Insulin Resistance in Breast Cancer Survivors
Document Type
article
Source
Nutrients. 13(9)
Subject
Nutrition
Diabetes
Rehabilitation
Cancer
Clinical Trials and Supportive Activities
Clinical Research
Obesity
Prevention
Breast Cancer
Evaluation of treatments and therapeutic interventions
6.7 Physical
Metabolic and endocrine
Blood Glucose
Breast Neoplasms
C-Peptide
Cancer Survivors
Exercise Therapy
Female
Humans
Insulin
Insulin Resistance
Middle Aged
Neoplasm Recurrence
Local
Weight Reduction Programs
breast neoplasms
neoplasm recurrence
weight reduction program
resistance training
overweight
adiposity
caloric restriction
biomarkers
Food Sciences
Nutrition and Dietetics
Language
Abstract
Obesity-associated breast cancer recurrence is mechanistically linked with elevated insulin levels and insulin resistance. Exercise and weight loss are associated with decreased breast cancer recurrence, which may be mediated through reduced insulin levels and improved insulin sensitivity. This is a secondary analysis of the WISER Survivor clinical trial examining the relative effect of exercise, weight loss and combined exercise and weight loss interventions on insulin and insulin resistance. The weight loss and combined intervention groups showed significant reductions in levels of: insulin, C-peptide, homeostatic model assessment 2 (HOMA2) insulin resistance (IR), and HOMA2 beta-cell function (β) compared to the control group. Independent of intervention group, weight loss of ≥10% was associated with decreased levels of insulin, C-peptide, and HOMA2-IR compared to 0-5% weight loss. Further, the combination of exercise and weight loss was particularly important for breast cancer survivors with clinically abnormal levels of C-peptide.